EMILY LAMPSHIRE: Open Payments
NPI 1912446790 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 23 payments from 5 companies in 2025. Trend: 2023 $1,843 · 2024 $2,338 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $364 |
| Eisai Inc. | 10 | $139 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: QULIPTA, Leqembi, UBRELVY, BOTOX, WAINUA, EMGALITY, AJOVY.
Industry payments across NY — which companies pay providers there.
